Treatment of Urinary Tract Infections in Pregnancy
For pregnant women with UTIs, the recommended first-line treatments are nitrofurantoin (100 mg twice daily for 5 days) or cephalexin (500 mg four times daily for 5-7 days), as these antibiotics have the best safety profiles during pregnancy while maintaining high efficacy against common uropathogens.
Diagnosis Considerations
- UTIs occur in approximately 8% of pregnant women 1
- Untreated UTIs during pregnancy can lead to serious complications:
- Pyelonephritis
- Preterm labor
- Low birth weight
- Sepsis
Antibiotic Treatment Options for UTIs in Pregnancy
First-Line Treatments
Nitrofurantoin:
- Dosage: 100 mg twice daily
- Duration: 5 days
- Advantages: High urinary concentration, low resistance rates
- Caution: Avoid in third trimester due to risk of hemolytic anemia in the newborn
- Contraindication: Avoid if CrCl <30 mL/min 2
Cephalexin:
- Dosage: 500 mg four times daily
- Duration: 5-7 days
- Advantages: Excellent safety profile throughout pregnancy 2
Alternative Options
Amoxicillin-clavulanate:
- Dosage: 500/125 mg twice daily
- Duration: 5-7 days
- Consider when first-line agents cannot be used 2
Fosfomycin:
- Dosage: 3 g single dose
- Advantages: Convenient single-dose administration
- Note: Limited data on use in pregnancy, but included in guidelines for short-course treatment 3
Antibiotics to Avoid or Use with Caution
Trimethoprim-sulfamethoxazole:
- Avoid in first trimester (risk of neural tube defects)
- Avoid in third trimester (risk of kernicterus) 2
Fluoroquinolones (e.g., ciprofloxacin):
- Contraindicated due to risk of damage to fetal cartilage 2
Duration of Treatment
- For asymptomatic bacteriuria or uncomplicated cystitis: 5-7 days of therapy is recommended 3
- Single-dose therapy is generally less effective than multi-day regimens, except for fosfomycin 3
- The Infectious Diseases Society of America (IDSA) recommends 4-7 days of antimicrobial therapy for pregnant women with asymptomatic bacteriuria 3
Treatment Algorithm
Confirm diagnosis:
- Urine culture should be obtained before starting antibiotics
- Positive culture: >100,000 CFU/mL of a single uropathogen
Select appropriate antibiotic:
- First-line: Nitrofurantoin or cephalexin
- Alternative: Amoxicillin-clavulanate or fosfomycin
- Consider local resistance patterns when selecting therapy
Monitor response:
- Follow-up urine culture 1-2 weeks after treatment completion
- If symptoms persist or recur, obtain repeat culture and adjust antibiotics based on susceptibility
Prevention of recurrence:
- For women with history of recurrent UTIs during pregnancy, consider prophylaxis
- Options include postcoital prophylaxis with nitrofurantoin 50 mg or cephalexin 250 mg 4
Special Considerations
Asymptomatic Bacteriuria
- Screen for and treat asymptomatic bacteriuria in pregnant women 3
- Treatment reduces the risk of pyelonephritis, preterm birth, and low birth weight
Recurrent UTIs in Pregnancy
- For women with history of recurrent UTIs, postcoital prophylaxis has been shown to be highly effective 4
- In one study, postcoital prophylaxis with either cephalexin (250 mg) or nitrofurantoin (50 mg) reduced UTI recurrence from 130 infections pre-prophylaxis to only 1 during pregnancy 4
Pyelonephritis
- Requires more aggressive treatment, often initially with parenteral antibiotics
- Consider hospitalization, especially in first and third trimesters
- Common IV options include ceftriaxone until clinical improvement, then transition to oral therapy 2
Common Pitfalls to Avoid
- Failure to obtain follow-up cultures: Always confirm cure with a post-treatment urine culture
- Inadequate treatment duration: Short-course therapy (except fosfomycin) is associated with higher failure rates in pregnancy
- Using contraindicated antibiotics: Avoid fluoroquinolones and tetracyclines throughout pregnancy
- Ignoring asymptomatic bacteriuria: Unlike in non-pregnant women, asymptomatic bacteriuria requires treatment during pregnancy
- Delaying treatment: Prompt treatment is essential to prevent complications
By following these evidence-based recommendations, clinicians can effectively manage UTIs during pregnancy while minimizing risks to both mother and fetus.